spironolactone has been researched along with glycyrrhizic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Gomez-Sanchez, CE; Gomez-Sanchez, EP | 1 |
| Kageyama, Y; Saruta, T; Suzuki, H | 1 |
| Ricketts, ML; Stewart, PM; Whorwood, CB | 1 |
| Lüscher, TF; Quaschning, T; Ruschitzka, F; Shaw, S | 1 |
| Christ, M; Lunt, CM; Lüscher, TF; Niggli, B; Quaschning, T; Ruschitzka, F; Shaw, S; Wehling, M | 1 |
| Ito, H; Shibata, H | 1 |
| Miyamori, I | 1 |
| Asano, Y; Homma, S; Inaba, T; Kusano, E; Muto, S; Onishi, A; Shuto, R | 1 |
| Liu, X; Wang, Q; Xu, R; Yang, J; Zang, M; Zhang, J | 1 |
2 review(s) available for spironolactone and glycyrrhizic acid
| Article | Year |
|---|---|
[Treatment for symptoms of pseudoaldosteronism].
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Diet, Sodium-Restricted; Glycyrrhiza; Glycyrrhizic Acid; Humans; Hydrocortisone; Hyperaldosteronism; Kidney Tubules, Collecting; Mineralocorticoid Receptor Antagonists; Potassium; Receptors, Mineralocorticoid; Sodium; Spironolactone | 2007 |
[Drug-induced pseudoaldosteronism].
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Early Diagnosis; Glycyrrhiza; Glycyrrhizic Acid; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Spironolactone | 2007 |
9 other study(ies) available for spironolactone and glycyrrhizic acid
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone.
Topics: Administration, Oral; Animals; Blood Pressure; Brain; Carbenoxolone; Corticosterone; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hypertension; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley; Spironolactone | 1992 |
Role of glucocorticoid in the development of glycyrrhizin-induced hypertension.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenalectomy; Aldosterone; Animals; Blood Pressure; Corticosterone; Desoxycorticosterone; Dexamethasone; Glucocorticoids; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hydroxysteroid Dehydrogenases; Hypertension; Male; Mineralocorticoids; Potassium; Rats; Rats, Wistar; Renin; Spironolactone | 1994 |
Regulation of sodium-potassium adenosine triphosphate subunit gene expression by corticosteroids and 11 beta-hydroxysteroid dehydrogenase activity.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenal Cortex Hormones; Animals; Gene Expression Regulation; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hydroxysteroid Dehydrogenases; Kidney; Male; Mifepristone; Rats; Rats, Wistar; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Spironolactone | 1994 |
Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Aorta; Blood Pressure; Body Weight; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Eplerenone; Glycyrrhiza; Glycyrrhizic Acid; Heart Rate; Hydroxysteroid Dehydrogenases; Hypertension; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Molecular Structure; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Plants, Medicinal; Rats; Rats, Inbred WKY; Spironolactone; Vasodilation | 2001 |
Influence of aldosterone vs. endothelin receptor antagonism on renovascular function in liquorice-induced hypertension.
Topics: Animals; Blood Vessels; Endothelin Receptor Antagonists; Endothelium, Vascular; Glycyrrhiza; Glycyrrhizic Acid; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Norepinephrine; Potassium Chloride; Rats; Rats, Inbred WKY; Renal Artery; Renal Circulation; Spironolactone; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2001 |
Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia.
Topics: Aged; Biomarkers; Glycyrrhizic Acid; Humans; Hydrocortisone; Hypocalcemia; Hypophosphatemia; Liddle Syndrome; Male; Mineralocorticoid Receptor Antagonists; Pneumonia; Renal Tubular Transport, Inborn Errors; Risk Factors; Spironolactone; Time Factors; Treatment Outcome; Up-Regulation; Urinary Calculi | 2010 |
Changes in pharmacokinetic profiles of acetaminophen and its glucuronide after pretreatment with combinations of N-acetylcysteine and either glycyrrhizin, silibinin or spironolactone in rat.
Topics: Acetaminophen; Acetylcysteine; Animals; Glycyrrhizic Acid; Hepatobiliary Elimination; Injections, Intraperitoneal; Liver; Male; Rats, Sprague-Dawley; Silybin; Silymarin; Spironolactone; Time Factors | 2014 |